Sensitivity to clopidogrel and outcomes of long-term dual antiplatelet therapy in patients with multifocal atherosclerosis

• Main Authors: M. B. Khakimova (Author), A. L. Komarov (Author), A. B. Dobrovolsky (Author), E. V. Titaeva (Author), V. V. Kadochnikova (Author), D. D. Abramov (Author), E. P. Panchenko (Author)
• Format: Book
• Published: «REMEDIUM GROUP» Ltd., 2024-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Introduction. Patients undergoing elective myocardial revascularization require 6 months of dual antiplatelet therapy (DAPT), including aspirin and clopidogrel. In patients with multifocal atherosclerotic lesion (MFA), it may be reasonable to extend the DAPT. Additional consideration of laboratory p...